Skip to main content
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.04
-0.17 (-1.20%)
At close: Apr 28, 2026, 4:00 PM EDT
14.04
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Adaptive Biotechnologies Operating Metrics

Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Number of Clonoseq Tests Delivered
96.49K 88.98K 82.18K 76.11K 70.84K 66.31K 61.46K 56.50K
Number of Clonoseq Tests Delivered Growth
36.21% 34.19% 33.72% 34.71% 37.98% 44.41% 48.98% 53.23%

Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
MRD
190.60M 171.28M 156.62M 145.53M 136.14M 123.34M 113.94M 102.74M
MRD Growth
40.00% 38.87% 37.46% 41.65% 36.03% 29.33% 25.53% 17.90%
Immune Medicine
62.16M 33.94M 32.90M 33.43M 41.14M 45.43M 60.56M 67.54M
Immune Medicine Growth
51.09% -25.29% -45.67% -50.50% -48.32% -51.79% -35.27% -31.20%

Immune Medicine Revenue Breakdown
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Collaboration
44.78M 14.55M 12.36M 13.45M 17.87M 22.37M 38.15M 42.58M
Collaboration Growth
150.58% -34.98% -67.59% -68.41% -64.93% -65.19% -38.27% -35.86%
Immune Medicine Service
17.38M 19.39M 20.54M 19.98M 23.27M 23.06M 22.42M 24.96M
Immune Medicine Service Growth
-25.31% -15.89% -8.37% -19.96% -18.79% -23.09% -29.43% -21.46%

Adjusted EBITDA by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024
Immune
5.36M -23.56M -24.52M -26.01M
MRD
-1.79M -14.87M -28.08M -41.22M

MRD Revenue Breakdown
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Service
174.10M 156.28M 144.12M 133.03M 123.64M 115.84M 109.44M 102.74M
Service Growth
40.81% 34.91% 31.69% 29.48% 26.06% 24.07% 24.69% 26.61%
Regulatory Milestone
16.50M 15.00M 12.50M - 12.50M 7.50M 4.50M -
Regulatory Milestone Growth
32.00% 100.00% 177.78% - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.